Location Greater Chicago Area, United States, North America Regions Great Lakes Gender Male
LinkedIn View on LinkedIn
Tom joined BioGenerator in June 2012 as a Senior Entrepreneur in Residence to help build portfolio companies and to launch new companies. Recently, Tom launched GeneriCo, as Pres. & CEO, which a specialty generic drug company during his EIR tenure. He is also the Chairman of the Board for Vasculox, Inc., a portfolio company with a biologic
initially targeted for organ transplant rejection caused by ischemic reperfusion injury. Also, Tom is working with Washington University’s Dr. Sam Wickline, on a nano drug technology company called AcuPlaq, LLC.
Tom possesses extensive biotechnology and pharmaceutical executive experience. He has worked in most therapeutic areas, including brands, generics, over-the-counter products, and biologics. His successes demonstrate leadership, empowerment of teams, and investor, Board/C level stakeholder influence skills. He has impacted strategic, commercial and implementation results in large, mid-market, and start-up companies. With Tom's core capabilities in strategy, identifying growth opportunities, spotting innovative product offerings, due diligence and execution, he has created over $30B in value and over $2B in new product offerings via business development, licensing, partnering, and M&A across 13 countries (including China and Japan). He is also an expert commercial and business development innovator, prospector and negotiator accomplished in closing deals with full integration with adaptive skills
